GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Value
Increase
Decrease
Funds Holding
5,365
Funds Holding Change
+8
Funds Holding Growth
+0.1%
Value
$1.31T
Holding in Top 10
768
Top 10 Change
+100
Top 10 Growth
+15%
Value Growth
+7%
New
235
Increased
2,555
Reduced
2,219
Closed
146
Capital Inflow
$92.4B
Capital Outflow
$40.4B
Net Capital Flow
+$52B
Capital Flow Change
+$44.9B
Calls
$21.9B
Puts
$22.3B
Net Calls
-$443M
Put/Call Ratio
1.02